Author

Ulrika Wimmercranz Marking

Public Health Agency of SwedenORCID 0000-0002-5580-4191Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Charlotte ThåliniD· 1 shared Daniel J. ShewardiD· 1 shared Jonas KlingströmiD· 1 shared Katherina Aguilera· 1 shared Kim G. BlomiD· 1 shared Mikael ÅbergiD· 1 shared Nina Greilert‐NoriniD· 1 shared Oscar BladhiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Charlotte ThålinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyThe Lancet Infectious DiseasesPeer-reviewedJan 5, 2024

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster

Ulrika Wimmercranz Marking, Oscar Bladh, Katherina Aguilera…·Charlotte Thålin

This study shows that a monovalent XBB.1.5-adapted BNT162b2 booster vaccine enhances binding and neutralizing antibodies against XBB.1.5 and BA.2.86 in elderly individuals with prior vaccinations.

29 citationstop 1%

humanproteomics

𝕏 PostBluesky